Company Profiles

driven by the PitchBook Platform

Albireo

Description

Developer of therapeutic drugs for gastrointestinal diseases. The company develops A3309, an oral compound for the treatment of patients with chronic idiopathic constipation.

2008

Founded

PRIVATE

Status

M&A

Latest Deal Type

$40M

Total Amount Raised

8

Investors

Description

Developer of therapeutic drugs for gastrointestinal diseases. The company develops A3309, an oral compound for the treatment of patients with chronic idiopathic constipation.

Website:

www.albireopharma.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Primary Office

Arvid Wallgrens Backe 20 413 46 GothenburgSweden +46 (0)3 174 11 480
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Albireo's full profile, request a free trial.

Albireo Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Albireo Investors (8)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Aberdeen Asset ManagementAsset ManagerMinority000 0000000 0000
AstraZenecaCorporationMinority000 0000000 0000
Kreos CapitalGrowth/ExpansionMinority000 0000000 0000
Phase4 PartnersVenture CapitalMinority000 0000000 0000
Scottish Widows Investment PartnershipFund of FundsMinority000 0000000 0000
Aberdeen Asset Management Asset Manager
AstraZeneca Corporation
Kreos Capital Growth/Expansion
Phase4 Partners Venture Capital
Scottish Widows Investment Partnership Fund of Funds

Albireo Executive Team (8)

NameTitleBoard
Seat
Contact
Info
Carsten DehningActing Chief Financial Officer
Jan Mattsson Ph.DChief Operating Officer & Co-Founder
Björn ErlandssonDirector, Finance & Operations
Per-Göran GillbergVice President, Development & Co-Founder
Pete Zorn JDSenior Vice President of Corporate Development & General Counsel
Carsten Dehning Acting Chief Financial Officer
Jan Mattsson Ph.D Chief Operating Officer & Co-Founder
Björn Erlandsson Director, Finance & Operations
Per-Göran Gillberg Vice President, Development & Co-Founder
Pete Zorn JD Senior Vice President of Corporate Development & General Counsel

Albireo Board Members (7)

NameRepresentingRoleSinceContact
Info
Alexandra Goll Ph.DTVM CapitalBoard Member000 0000
David Chiswell Ph.DSelfChairman000 0000
Denise Scots-Knight Ph.DPhase4 PartnersBoard Member000 0000
Elisabeth BjorkSelfBoard Member000 0000
Heather Preston MDTPG BiotechBoard Member000 0000
Alexandra Goll Ph.D Board Member TVM Capital
David Chiswell Ph.D Chairman Self
Denise Scots-Knight Ph.D Board Member Phase4 Partners
Elisabeth Bjork Board Member Self
Heather Preston MD Board Member TPG Biotech
Request full access to PitchBook